The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 9,964 | 707,200 | SH | SOLE | 707,200 | 0 | 0 | ||
AfterNext HealthTech Acquisition Corp | *W EXP 99/99/999 | G01109126 | 70 | 366,666 | SH | SOLE | 366,666 | 0 | 0 | ||
Algoma Stl Group Inc | COM | 015658107 | 33,376 | 3,716,732 | SH | SOLE | 3,716,732 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 21,597 | 2,010,900 | SH | SOLE | 2,010,900 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 14,398 | 318,400 | SH | SOLE | 318,400 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 13,557 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
Ares Acquisition Corp | *W EXP 99/99/999 | G33032122 | 116 | 504,706 | SH | SOLE | 504,706 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 20,005 | 52,800 | SH | SOLE | 52,800 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 14,827 | 159,500 | SH | SOLE | 159,500 | 0 | 0 | ||
Berenson Acquisition Corp I | *W EXP 08/01/202 | 083690115 | 121 | 862,499 | SH | SOLE | 862,499 | 0 | 0 | ||
Bilander Acquisition Corp | *W EXP 05/19/202 | 09001T114 | 55 | 183,749 | SH | SOLE | 183,749 | 0 | 0 | ||
Bridgetown Holdings Ltd | *W EXP 09/30/202 | G1355U121 | 206 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
Catalyst Partners Acquisition | *W EXP 05/12/202 | G19550121 | 71 | 336,666 | SH | SOLE | 336,666 | 0 | 0 | ||
Churchill Capital Corp V | *W EXP 10/29/202 | 17144T115 | 202 | 612,000 | SH | SOLE | 612,000 | 0 | 0 | ||
Churchill Capital Corp VI | *W EXP 02/17/202 | 17143W119 | 184 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
Churchill Capital Corp VII | *W EXP 02/29/202 | 17144M110 | 191 | 548,000 | SH | SOLE | 548,000 | 0 | 0 | ||
Cohn Robbins Holdings Corp | *W EXP 08/28/202 | G23726113 | 389 | 904,000 | SH | SOLE | 904,000 | 0 | 0 | ||
Compass Digital Acquisition Corp | *W EXP 09/29/202 | G2476C123 | 115 | 459,906 | SH | SOLE | 459,906 | 0 | 0 | ||
Concord Acquisition Corp II | *W EXP 99/99/999 | 20607U116 | 90 | 408,333 | SH | SOLE | 408,333 | 0 | 0 | ||
Conyers Park III Acquisition Corp | *W EXP 08/12/202 | 21289P110 | 166 | 571,666 | SH | SOLE | 571,666 | 0 | 0 | ||
Corsair Partnering Corp | *W EXP 07/06/202 | G2540H116 | 67 | 334,666 | SH | SOLE | 334,666 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 16,480 | 419,433 | SH | SOLE | 419,433 | 0 | 0 | ||
Equity Distribution Acquisitio | *W EXP 09/09/202 | 29465E114 | 69 | 669,000 | SH | SOLE | 669,000 | 0 | 0 | ||
First Light Acquisition Group Inc | *W EXP 03/14/202 | 320703119 | 59 | 655,200 | SH | SOLE | 655,200 | 0 | 0 | ||
Fortress Capital Acquisition C | *W EXP 99/99/999 | G36427121 | 71 | 392,000 | SH | SOLE | 392,000 | 0 | 0 | ||
Fortress Value Acquisition Cor | *W EXP 12/31/202 | 34964G115 | 41 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
Fortress Value Acquisition Cor | *W EXP 03/18/202 | 34964K116 | 57 | 306,513 | SH | SOLE | 306,513 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 14,475 | 259,400 | SH | SOLE | 259,400 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 15,144 | 474,000 | SH | SOLE | 474,000 | 0 | 0 | ||
GLOBAL BUSINESS TRAVEL GROUP | *W EXP 99/99/9999 | 37890B118 | 959 | 913,000 | SH | SOLE | 913,000 | 0 | 0 | ||
Gores Technology Partners II Inc | *W EXP 03/16/202 | 38287L115 | 198 | 450,691 | SH | SOLE | 450,691 | 0 | 0 | ||
Gores Technology Partners Inc | *W EXP 03/16/202 | 382870111 | 105 | 201,000 | SH | SOLE | 201,000 | 0 | 0 | ||
Health Assurance Acquisition C | *W EXP 11/12/202 | 42226W117 | 87 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | ||
Home Plate Acquisition Corp | *W EXP 09/30/202 | 43734R111 | 124 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,601 | 960,200 | SH | SOLE | 960,200 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 9,501 | 987,600 | SH | SOLE | 987,600 | 0 | 0 | ||
Jaws Hurricane Acquisition Corp | *W EXP 03/26/202 | 47201B111 | 139 | 387,249 | SH | SOLE | 387,249 | 0 | 0 | ||
KKR Acquisition Holdings I Corp | *W EXP 99/99/999 | 48253T117 | 212 | 588,547 | SH | SOLE | 588,547 | 0 | 0 | ||
Levere Holdings Corp | *W EXP 03/09/202 | G5462L122 | 22 | 274,999 | SH | SOLE | 274,999 | 0 | 0 | ||
Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | 74 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 14,111 | 210,200 | SH | SOLE | 210,200 | 0 | 0 | ||
Music Acquisition Corp/The | *W EXP 02/05/202 | 62752R118 | 7 | 75,250 | SH | SOLE | 75,250 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 5,815 | 735,126 | SH | SOLE | 735,126 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 12,421 | 457,500 | SH | SOLE | 457,500 | 0 | 0 | ||
Revolution Healthcare Acquisit | *W EXP 12/31/202 | 76155Y116 | 108 | 432,639 | SH | SOLE | 432,639 | 0 | 0 | ||
Ross Acquisition Corp II | *W EXP 02/01/202 | G7641C114 | 68 | 439,666 | SH | SOLE | 439,666 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 15,362 | 475,600 | SH | SOLE | 475,600 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 15,817 | 211,000 | SH | SOLE | 211,000 | 0 | 0 | ||
Senior Connect Acquisition Cor | *W EXP 12/31/202 | 81723H116 | 71 | 1,014,000 | SH | SOLE | 1,014,000 | 0 | 0 | ||
Simon Property Group Acquisition Holdings Inc | *W EXP 02/04/202 | 82880R111 | 62 | 335,200 | SH | SOLE | 335,200 | 0 | 0 | ||
Skydeck Acquisition Corp | *W EXP 05/13/202 | G82220115 | 54 | 361,756 | SH | SOLE | 361,756 | 0 | 0 | ||
Social Capital Hedosophia Holdings Corp VI | *W EXP 09/26/202 | G8251L113 | 322 | 671,000 | SH | SOLE | 671,000 | 0 | 0 | ||
Starry Group Holdings Inc | *W EXP 99/99/999 | 85572U110 | 276 | 669,000 | SH | SOLE | 669,000 | 0 | 0 | ||
Summit Healthcare Acquisition Corp | *W EXP 06/03/202 | G8566R110 | 45 | 489,999 | SH | SOLE | 489,999 | 0 | 0 | ||
Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | 54 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 14,158 | 584,300 | SH | SOLE | 584,300 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 12,123 | 203,200 | SH | SOLE | 203,200 | 0 | 0 | ||
Warburg Pincus Capital Corp I-A | *W EXP 99/99/999 | G9461D115 | 5 | 14,999 | SH | SOLE | 14,999 | 0 | 0 | ||
Warburg Pincus Capital Corp I-B | *W EXP 99/99/999 | G9460M124 | 34 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Zimmer Energy Transition Acquisition Corp | *W EXP 06/16/202 | 989570114 | 115 | 358,270 | SH | SOLE | 358,270 | 0 | 0 |